Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Psychiatry
•
Neuromodulation
•
Major Depressive Disorder
•
Anxiety Disorders
•
General Psychiatry
What is your experience with transcutaneous vagal nerve stimulation for the treatment of anxiety disorders and major depressive disorder?
Answer from: at Community Practice
Just starting to recommend, have had a few folks with side effects and unclear results. A colleague noted about a 30-40% response rate.
Sign in or Register to read more
27301
Related Questions
How do you approach treatment-resistant depression and anxiety related to menopause refractory to SSRI/SNRIs and hormone replacement therapy?
What varying approaches do you take in suicide risk assessments?
How do you approach tapering electroconvulsive therapy after an acute treatment course leading to successful resolution of symptoms for treatment-resistant depression?
What do you do when a patient experiences multiple rounds of antidepressant-related tachyphylaxis?
When would you consider transdermal treatments for ADHD?
What strategies have you found helpful to manage SSRI associated night sweats?
What pharmacological management do you consider in patients with Autism Spectrum Disorder whose primary behavior is aggression?
How do you approach psychotropic (demonstrated SSRIs and antipsychotics) induced urinary retention when a patient is otherwise having good response to treatment?
What criteria do you use when deciding whether to start esketamine treatment for patients with treatment resistant MDD who are concomitant CNS depressants?
How do you approach patients who identify so strongly with being sick or with a particular diagnostic label that it makes up a significant portion of their identity?